These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7692380)

  • 21. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands.
    Brimicombe RW; Dijkshoorn L; van der Reijden TJ; Kardoes I; Pitt TL; van den Broek PJ; Heijerman HG
    J Cyst Fibros; 2008 Jan; 7(1):30-6. PubMed ID: 17532271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas cepacia of the temporal bone: malignant external otitis in a patient with cystic fibrosis.
    Dettelbach MA; Hirsch BE; Weissman JL
    Otolaryngol Head Neck Surg; 1994 Oct; 111(4):528-32. PubMed ID: 7524007
    [No Abstract]   [Full Text] [Related]  

  • 23. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.
    Steinbach S; Sun L; Jiang RZ; Flume P; Gilligan P; Egan TM; Goldstein R
    N Engl J Med; 1994 Oct; 331(15):981-7. PubMed ID: 7521938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burkholderia cepacia and cystic fibrosis--50 years on.
    Moore JE; Elborn JS
    Commun Dis Public Health; 2001 Jun; 4(2):114-6. PubMed ID: 11524998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas cepacia in cystic fibrosis patients.
    Prince A
    Am Rev Respir Dis; 1986 Oct; 134(4):644-5. PubMed ID: 3094414
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cystic fibrosis and Burkholderia (formerly Pseudomonas) cepacia: an increasing clinical and psychosocial problem].
    Horrevorts AM; Heijerman HG; Möller AV; Dankert-Roelse JE; Mouton JW; van der Laag J; Dankert J
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2343-6. PubMed ID: 7501071
    [No Abstract]   [Full Text] [Related]  

  • 27. Application of pyrolysis mass spectroscopy and SDS-PAGE in the study of the epidemiology of Pseudomonas cepacia in cystic fibrosis.
    Corkill JE; Sisson PR; Smyth A; Deveney J; Freeman R; Shears P; Heaf D; Hart CA
    J Med Microbiol; 1994 Aug; 41(2):106-11. PubMed ID: 7519269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.
    LiPuma JJ; Mortensen JE; Dasen SE; Edlind TD; Schidlow DV; Burns JL; Stull TL
    J Pediatr; 1988 Nov; 113(5):859-62. PubMed ID: 2903229
    [No Abstract]   [Full Text] [Related]  

  • 29. Burkholderia cepacia in cystic fibrosis.
    LiPuma JJ; Stull TL
    N Engl J Med; 1995 Mar; 332(12):820; author reply 820-1. PubMed ID: 7532286
    [No Abstract]   [Full Text] [Related]  

  • 30. Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia.
    Taylor RF; Gaya H; Hodson ME
    J Antimicrob Chemother; 1992 Mar; 29(3):341-4. PubMed ID: 1375595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment.
    Fisher MC; LiPuma JJ; Dasen SE; Caputo GC; Mortensen JE; McGowan KL; Stull TL
    J Pediatr; 1993 Nov; 123(5):745-7. PubMed ID: 7693902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa.
    Grassmé H; Becker KA; Zhang Y; Gulbins E
    Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].
    Segonds C; Chabanon G
    Ann Biol Clin (Paris); 2001; 59(3):259-69. PubMed ID: 11397673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center.
    Cunha MV; Pinto-de-Oliveira A; Meirinhos-Soares L; Salgado MJ; Melo-Cristino J; Correia S; Barreto C; Sá-Correia I
    J Clin Microbiol; 2007 May; 45(5):1628-33. PubMed ID: 17360834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications.
    Burdge DR; Noble MA; Campbell ME; Krell VL; Speert DP
    Clin Infect Dis; 1995 Feb; 20(2):445-8. PubMed ID: 7537977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis.
    Thomassen MJ; Demko CA; Doershuk CF; Stern RC; Klinger JD
    Am Rev Respir Dis; 1986 Oct; 134(4):669-71. PubMed ID: 3767122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of Pseudomonas cepacia in cystic fibrosis patient.
    Marques Ede A; Pinto RM; Dallallana LT; de Oliveira EF; Suassuna I
    Mem Inst Oswaldo Cruz; 1993; 88(1):125-9. PubMed ID: 7504157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of evidence of transmission of Pseudomonas aeruginosa among cystic fibrosis patients attending health camps at the Dead Sea, Israel.
    Greenberg D; Yagupsky P; Peled N; Goldbart A; Porat N; Tal A
    Isr Med Assoc J; 2004 Sep; 6(9):531-4. PubMed ID: 15373310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.